Loomis, Sayles & Company’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CYRX
FAM
BCM
GIP
Loomis, Sayles & Company's CYRX Position: Q1 2022 in Review
Loomis, Sayles & Company sold out of CryoPort (CYRX) in Q1 2022, closing a stake of 862,710 shares — an estimated $51M sold.
Loomis, Sayles & Company first reported a position in CYRX in Q2 2020 and held it in 7 quarters. The position peaked at $58.8M in Q3 2021. 200 funds tracked by Wall St. Rank hold CYRX as of Q1 2022.
- Loomis, Sayles & Company reported no remaining CryoPort position as of Q1 2022 after selling out during the quarter.
- Loomis, Sayles & Company sold 862,710 CryoPort shares in Q1 2022, an estimated $51M.
- Loomis, Sayles & Company first reported a position in CryoPort in Q2 2020 and held it in 7 quarters.
- Loomis, Sayles & Company's CryoPort position peaked at $58.8M in Q3 2021.
- 200 funds tracked by Wall St. Rank held CryoPort as of Q1 2022.
Based on Loomis, Sayles & Company's 13F filing for Q1 2022, filed 13 May 2022.